Bank of America’s ARK Genomic Revolution ETF ARKG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $23.1M | Sell |
873,702
-480,026
| -35% | -$14.1M | ﹤0.01% | 2268 |
|
|
2025
Q4 | $39.2M | Buy |
1,353,728
+968,626
| +252% | +$29.1M | ﹤0.01% | 1727 |
|
|
2025
Q3 | $10.7M | Sell |
385,102
-53,975
| -12% | -$1.36M | ﹤0.01% | 3227 |
|
|
2025
Q2 | $10.7M | Sell |
439,077
-765,844
| -64% | -$16.8M | ﹤0.01% | 3176 |
|
|
2025
Q1 | $25M | Sell |
1,204,921
-1,577,449
| -57% | -$39.6M | ﹤0.01% | 2213 |
|
|
2024
Q4 | $65.5M | Sell |
2,782,370
-120,557
| -4% | -$2.97M | 0.01% | 1300 |
|
|
2024
Q3 | $74.3M | Buy |
2,902,927
+1,446,547
| +99% | +$36.8M | 0.01% | 1260 |
|
|
2024
Q2 | $34.2M | Buy |
1,456,380
+607,868
| +72% | +$15.3M | ﹤0.01% | 1768 |
|
|
2024
Q1 | $24.4M | Buy |
848,512
+42,827
| +5% | +$1.29M | ﹤0.01% | 2086 |
|
|
2023
Q4 | $26.4M | Sell |
805,685
-34,264
| -4% | -$932K | ﹤0.01% | 1878 |
|
|
2023
Q3 | $23.4M | Sell |
839,949
-825,589
| -50% | -$27M | ﹤0.01% | 1870 |
|
|
2023
Q2 | $56.8M | Sell |
1,665,538
-868,239
| -34% | -$27.3M | 0.01% | 1217 |
|
|
2023
Q1 | $76.2M | Buy |
2,533,777
+921,127
| +57% | +$28.5M | 0.01% | 1094 |
|
|
2022
Q4 | $45.5M | Buy |
1,612,650
+421,637
| +35% | +$13.4M | 0.01% | 1370 |
|
|
2022
Q3 | $39.1M | Sell |
1,191,013
-167,730
| -12% | -$6.16M | ﹤0.01% | 1440 |
|
|
2022
Q2 | $42.8M | Sell |
1,358,743
-502,372
| -27% | -$17.6M | ﹤0.01% | 1372 |
|
|
2022
Q1 | $85.5M | Buy |
1,861,115
+228,665
| +14% | +$10.9M | 0.01% | 1038 |
|
|
2021
Q4 | $100M | Sell |
1,632,450
-421,343
| -21% | -$29.1M | 0.01% | 994 |
|
|
2021
Q3 | $153M | Sell |
2,053,793
-475,020
| -19% | -$39.9M | 0.02% | 748 |
|
|
2021
Q2 | $234M | Buy |
2,528,813
+577,866
| +30% | +$49.1M | 0.02% | 564 |
|
|
2021
Q1 | $173M | Buy |
1,950,947
+887,807
| +84% | +$88.1M | 0.02% | 634 |
|
|
2020
Q4 | $99.1M | Buy |
1,063,140
+611,717
| +136% | +$48.7M | 0.01% | 794 |
|
|
2020
Q3 | $28.8M | Buy |
451,423
+126,934
| +39% | +$7.44M | ﹤0.01% | 1430 |
|
|
2020
Q2 | $16.9M | Buy |
324,489
+189,255
| +140% | +$8.12M | ﹤0.01% | 1749 |
|
|
2020
Q1 | $4.23M | Buy |
135,234
+108,201
| +400% | +$3.62M | ﹤0.01% | 2813 |
|
|
2019
Q4 | $906K | Buy |
27,033
+25,295
| +1,455% | +$804K | ﹤0.01% | 4576 |
|
|
2019
Q3 | $51K | Buy |
1,738
+25
| +1% | +$813 | ﹤0.01% | 6316 |
|
|
2019
Q2 | $59K | Buy |
1,713
+613
| +56% | +$19.6K | ﹤0.01% | 6228 |
|
|
2019
Q1 | $36K | Buy |
1,100
+650
| +144% | +$19.2K | ﹤0.01% | 6315 |
|
|
2018
Q4 | $11K | Sell |
450
-10,413
| -96% | -$293K | ﹤0.01% | 6615 |
|
|
2018
Q3 | $363K | Hold |
10,863
| – | – | ﹤0.01% | 5149 |
|
|
2018
Q2 | $316K | Buy |
10,863
+1,140
| +12% | +$31.7K | ﹤0.01% | 5159 |
|
|
2018
Q1 | $250K | Buy |
+9,723
| New | +$263K | ﹤0.01% | 5243 |
|
Other funds holding ARKG
JFG
Bank of America's ARKG Position: Q1 2026 in Review
Bank of America reduced its ARK Genomic Revolution ETF (ARKG) stake by 35% in Q1 2026, selling an estimated $14.1M and leaving 873,702 shares worth $23.1M. The position accounts for ﹤0.01% of the portfolio, ranked #2268.
Bank of America first reported a position in ARKG in Q1 2018 and has held it in 33 quarters since. The position peaked at $234M in Q2 2021. 218 funds tracked by Wall St. Rank hold ARKG as of Q1 2026.
- Bank of America held 873,702 shares of ARK Genomic Revolution ETF worth $23.1M as of Q1 2026.
- Bank of America sold 480,026 ARK Genomic Revolution ETF shares in Q1 2026, an estimated $14.1M.
- ARK Genomic Revolution ETF made up ﹤0.01% of Bank of America's portfolio in Q1 2026, its #2268 holding.
- Bank of America first reported a position in ARK Genomic Revolution ETF in Q1 2018 and has held it in 33 quarters since.
- Bank of America's ARK Genomic Revolution ETF position peaked at $234M in Q2 2021.
- 218 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q1 2026.
Based on Bank of America's 13F filing for Q1 2026, filed 18 May 2026.